Rullan Peter P, Olson Rachel, Lee Kachiu C
Dr. Rullan is with the Department of Dermatology, University of California San Diego in La Jolla, California and the Dermatology Institute in Chula Vista, California.
Ms. Olson is with the Dermatology Institute in Chula Vista, California. Dr. Lee is with the Department of Dermatology at Brown University in Providence, Rhode Island.
J Clin Aesthet Dermatol. 2020 May;13(5):19-23. Epub 2020 May 1.
Acne is a common condition that often results in scarring. Current treatment options, such as chemical peels, laser therapy, radiofrequency, subcision, and microneedling, all have some efficacy in the treatment of acne scars. Results can vary based on the type of scarring and the treatment modality used. We propose a novel treatment of acne scarring using a multimodal approach comprising chemical reconstruction of skin scars, subcision, and microneedling. A retrospective chart review was conducted from January 2017 to December 2018 of all patients with acne scars treated with a triple combination approach in an outpatient cosmetic dermatology practice. Patients presenting with acne scarring who were 18 years of age or older and treated with the triple combination technique were eligible for inclusion. Each patient was treated with a combination of three procedures: 1) chemical reconstruction of skin scars (CROSS), mainly with carbolic acid; 2) blunt bi-level cannula subcision; and 3) microneedling. A total of 139 patients were treated, of whom 89 (64%) had Fitzpatrick Skin Types IV to VI. Shadow-lit before and after photos and patient feedback on side effects and satisfaction level were used to assess changes. On average, patients received a total of two treatments each (range: 1-4 treatments). This triple approach to treating acne scars resulted in consistently high satisfaction among patients and photographic evidence of improvements. The triple combination of CROSS (to stimulate neocollagenesis), subcision (to release dermal connective tissue tethering), and microneedling (to stimulate neocollagenesis) appears to be effective for the treatment of acne scars. Randomized, controlled clinical trials with larger patient numbers are needed to support these observations.
痤疮是一种常见病症,常导致瘢痕形成。目前的治疗方法,如化学换肤、激光治疗、射频、皮下分离术和微针治疗,在治疗痤疮瘢痕方面都有一定疗效。治疗效果会因瘢痕类型和所采用的治疗方式而有所不同。我们提出一种治疗痤疮瘢痕的新方法,即采用包括皮肤瘢痕化学重建、皮下分离术和微针治疗的多模式方法。对2017年1月至2018年12月期间在门诊美容皮肤科采用三联组合方法治疗的所有痤疮瘢痕患者进行了回顾性病历审查。年龄在18岁及以上且采用三联组合技术治疗的痤疮瘢痕患者符合纳入标准。每位患者均接受三种治疗的联合应用:1)皮肤瘢痕化学重建(CROSS),主要使用石炭酸;2)钝性双平面套管皮下分离术;3)微针治疗。共治疗了139例患者,其中89例(64%)为Fitzpatrick皮肤分型IV至VI型。使用阴影照明的前后照片以及患者对副作用和满意度的反馈来评估变化。患者平均每人共接受两次治疗(范围:1 - 4次治疗)。这种治疗痤疮瘢痕的三联方法在患者中获得了持续较高的满意度,并通过照片证明有改善。CROSS(刺激新胶原形成)、皮下分离术(松解真皮结缔组织束缚)和微针治疗(刺激新胶原形成)的三联组合似乎对治疗痤疮瘢痕有效。需要更多患者参与的随机对照临床试验来支持这些观察结果。